A joint venture team of Shorenstein Properties and SKS Development is in contract to buy 25 acres of waterfront land at Oyster Point, a deal that will put the team in control of the largest and most valuable biotech play left in South San Francisco.
A joint venture team of Shorenstein Properties and SKS Development is in contract to buy 25 acres of waterfront land at Oyster Point, a deal that will put the team in control of the largest and most valuable biotech play left in South San Francisco.
